Mariathasan, Sanjeev
Genentech, Inc,
United States
2025 Rank: 61223
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1743 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 61223 | 69962 |
| Total Cites | 23412 | 25241 |
| H-index | 49 | 51 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 58 | 58 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 8775 | 9029 |
| Number of Single+First+Last Authored Papers | 20 | 20 |
| Total Cites to Single+First+Last Authored Papers | 10100 | 10436 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 18796 | 19757 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.28 |
| Self-Citation Percentage |
7.25%
|
|
Mariathasan, Sanjeev
Genentech, Inc,
United States
2024 Rank: 64646
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1854 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 64646 | 72885 |
| Total Cites | 20866 | 22505 |
| H-index | 45 | 48 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 57 | 57 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 7976 | 8212 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 8999 | 9295 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 16712 | 17576 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.28 |
| Self-Citation Percentage |
7.28%
|
|
Mariathasan, Sanjeev
Genentech, Inc,
United States
2023 Rank: 69790
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2007 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 69790 | 79056 |
| Total Cites | 18121 | 19639 |
| H-index | 40 | 42 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 55 | 55 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 7058 | 7285 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 7813 | 8081 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 14576 | 15386 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.28 |
| Self-Citation Percentage |
7.73%
|
|
Mariathasan, Sanjeev
Genentech Incorporated,
United States
2022 Rank: 71350
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2097 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 71350 | 82412 |
| Total Cites | 15325 | 16637 |
| H-index | 39 | 40 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 53 | 53 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 6015 | 6226 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 6537 | 6772 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12337 | 13061 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.27 |
| Self-Citation Percentage |
7.89%
|
|
Mariathasan, Sanjeev
Genentech Incorporated,
United States
2021 Rank: 73773
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Developmental Biology
Rank in SubField 1: 2149 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 73773 | 84019 |
| Total Cites | 14150 | 15382 |
| H-index | 37 | 39 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 51 | 51 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 5604 | 5802 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 6053 | 6271 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11411 | 12104 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.27 |
| Self-Citation Percentage |
8.01%
|
|
Mariathasan, Sanjeev
Genentech Incorporated,
United States
2020 Rank: 80642
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 2297 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 80642 | 92916 |
| Total Cites | 11486 | 12498 |
| H-index | 32 | 33 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 49 | 49 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 4684 | 4854 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 4975 | 5165 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9296 | 9902 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.26 |
| Self-Citation Percentage |
8.10%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.